These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 35884634)
1. Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs. Petralia MC; Mangano K; Quattropani MC; Lenzo V; Nicoletti F; Fagone P Brain Sci; 2022 Jun; 12(7):. PubMed ID: 35884634 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs. Fagone P; Mangano K; Martino G; Quattropani MC; Pennisi M; Bella R; Fisicaro F; Nicoletti F; Petralia MC Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456509 [TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer's disease and frontotemporal dementia. Pagnon de la Vega M; Näslund C; Brundin R; Lannfelt L; Löwenmark M; Kilander L; Ingelsson M; Giedraitis V BMC Genomics; 2022 Feb; 23(1):99. PubMed ID: 35120450 [TBL] [Abstract][Full Text] [Related]
4. Decoding the Role of Astrocytes in the Entorhinal Cortex in Alzheimer's Disease Using High-Dimensional Single-Nucleus RNA Sequencing Data and Next-Generation Knowledge Discovery Methodologies: Focus on Drugs and Natural Product Remedies for Dementia. Pushparaj PN; Kalamegam G; Wali Sait KH; Rasool M Front Pharmacol; 2021; 12():720170. PubMed ID: 35295737 [No Abstract] [Full Text] [Related]
5. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production. Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942 [TBL] [Abstract][Full Text] [Related]
6. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease. Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948 [TBL] [Abstract][Full Text] [Related]
7. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373 [TBL] [Abstract][Full Text] [Related]
8. Presenilin/gamma-Secretase and Inflammation. Saura CA Front Aging Neurosci; 2010; 2():16. PubMed ID: 20559464 [TBL] [Abstract][Full Text] [Related]
9. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau. Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307 [TBL] [Abstract][Full Text] [Related]
10. Network-based identification of miRNAs and transcription factors and Iqbal S; Malik MZ; Pal D Heliyon; 2021 Dec; 7(12):e08502. PubMed ID: 34917801 [TBL] [Abstract][Full Text] [Related]
12. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage. Zhang C; Browne A; Kim DY; Tanzi RE Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669 [TBL] [Abstract][Full Text] [Related]
13. Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort. Jin SC; Pastor P; Cooper B; Cervantes S; Benitez BA; Razquin C; Goate A; ; Cruchaga C Alzheimers Res Ther; 2012 Aug; 4(4):34. PubMed ID: 22906081 [TBL] [Abstract][Full Text] [Related]
14. Integrated analysis and network pharmacology approaches to explore key genes of Xingnaojing for treatment of Alzheimer's disease. Wang M; Wang S; Li Y; Cai G; Cao M; Li L Brain Behav; 2020 Jun; 10(6):e01610. PubMed ID: 32304290 [TBL] [Abstract][Full Text] [Related]
15. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis. Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014 [TBL] [Abstract][Full Text] [Related]
17. Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer's Disease. El Kadmiri N; Zaid N; Zaid Y; Tadevosyan A; Hachem A; Dubé MP; Hamzi K; El Moutawakil B; Slassi I; Nadifi S Neuroscience; 2014 Jun; 269():215-22. PubMed ID: 24704512 [TBL] [Abstract][Full Text] [Related]
18. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease. Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961 [TBL] [Abstract][Full Text] [Related]
19. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology. Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290 [TBL] [Abstract][Full Text] [Related]